P23193
Gene name |
TCEA1 (GTF2S, TFIIS) |
Protein name |
Transcription elongation factor A protein 1 |
Names |
Transcription elongation factor S-II protein 1, Transcription elongation factor TFIIS.o |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:6917 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
16 structures for P23193
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| 1TFI | NMR | - | A | 252-301 | PDB |
| 3NDQ | X-ray | 193 A | A | 131-232 | PDB |
| 5IY6 | EM | 720 A | U | 1-301 | PDB |
| 5IY7 | EM | 860 A | U | 1-301 | PDB |
| 5IY8 | EM | 790 A | U | 1-301 | PDB |
| 5IYA | EM | 540 A | U | 1-301 | PDB |
| 5IYB | EM | 390 A | U | 1-301 | PDB |
| 5IYC | EM | 390 A | U | 1-301 | PDB |
| 6O9L | EM | 720 A | U | 1-301 | PDB |
| 6ZUY | NMR | - | A | 1-79 | PDB |
| 6ZV4 | NMR | - | A | 1-77 | PDB |
| 7CNF | NMR | - | A | 1-96 | PDB |
| 7UNC | EM | 300 A | O | 1-301 | PDB |
| 7UND | EM | 300 A | O | 1-301 | PDB |
| 8A40 | EM | 300 A | U | 1-301 | PDB |
| AF-P23193-F1 | Predicted | AlphaFoldDB |
192 variants for P23193
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
|
rs1375131410 CA370980505 |
3 | D>G | No |
ClinGen TOPMed gnomAD |
|
|
CA370980507 rs1223834008 |
3 | D>N | No |
ClinGen gnomAD |
|
|
rs1445503734 CA370980498 |
4 | E>A | No |
ClinGen gnomAD |
|
|
CA370980501 rs1306655897 |
4 | E>K | No |
ClinGen gnomAD |
|
|
CA370980478 rs1459863450 |
7 | R>H | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
|
CA4750260 rs773210177 |
10 | K>E | No |
ClinGen ExAC gnomAD |
|
|
rs978660068 CA177216006 |
11 | K>Q | No |
ClinGen TOPMed |
|
|
CA370980441 rs1221851816 |
12 | M>I | No |
ClinGen TOPMed |
|
|
rs1405825593 CA370980447 |
12 | M>V | No |
ClinGen TOPMed gnomAD |
|
|
rs768622226 CA4750259 |
13 | D>G | No |
ClinGen ExAC gnomAD |
|
|
rs1454824200 CA370980430 |
14 | K>Q | No |
ClinGen gnomAD |
|
| TCGA novel | 15 | M>D | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1255362812 CA370980421 |
15 | M>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
|
CA4750256 rs745685647 |
20 | N>K | No |
ClinGen ExAC TOPMed |
|
|
rs775504643 CA4750257 |
20 | N>S | No |
ClinGen ExAC gnomAD |
|
|
rs1586048301 CA370980378 |
21 | A>T | No |
ClinGen Ensembl |
|
|
CA370980373 rs1255443914 |
21 | A>V | No |
ClinGen TOPMed |
|
|
CA370980355 rs1254012570 |
22 | A>V | No |
ClinGen TOPMed |
|
|
rs1189219542 CA370980344 |
24 | A>G | No |
ClinGen gnomAD |
|
|
CA370980343 rs1189219542 |
24 | A>V | No |
ClinGen gnomAD |
|
| TCGA novel | 27 | L>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
| TCGA novel | 32 | K>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1273767520 CA370980271 |
34 | I>M | No |
ClinGen TOPMed |
|
|
rs747721723 CA4750230 |
36 | M>I | No |
ClinGen ExAC gnomAD |
|
|
rs200607231 CA4750231 |
36 | M>V | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
rs1316035514 CA370980228 |
41 | L>P | No |
ClinGen gnomAD |
|
|
CA370980219 rs1277529452 |
42 | Q>H | No |
ClinGen gnomAD |
|
|
CA370980199 rs1221033268 |
44 | T>A | No |
ClinGen TOPMed |
|
|
CA370980198 rs1221033268 |
44 | T>S | No |
ClinGen TOPMed |
|
|
rs1279411676 CA370980191 |
45 | R>K | No |
ClinGen TOPMed |
|
|
rs906658429 CA177199580 |
46 | I>V | No |
ClinGen Ensembl |
|
| TCGA novel | 47 | G>* | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA370980181 rs1415755975 |
47 | G>R | No |
ClinGen gnomAD |
|
|
CA177199571 rs1042599521 |
48 | M>L | No |
ClinGen TOPMed gnomAD |
|
|
rs945554136 CA177199554 |
49 | S>L | No |
ClinGen Ensembl |
|
| TCGA novel | 51 | N>S | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA4750199 rs766368998 |
52 | A>T | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA4750198 rs762620701 |
52 | A>V | No |
ClinGen ExAC gnomAD |
|
|
CA4750196 rs764788189 |
53 | I>V | No |
ClinGen ExAC gnomAD |
|
|
CA370980136 rs1258249801 |
54 | R>C | No |
ClinGen gnomAD |
|
|
rs1212522845 CA370980128 |
55 | K>R | No |
ClinGen gnomAD |
|
|
CA4750194 rs776431199 |
65 | L>F | No |
ClinGen ExAC gnomAD |
|
|
CA370980037 rs1193354565 |
68 | S>F | No |
ClinGen TOPMed |
|
|
CA370980031 rs1256739538 |
69 | L>H | No |
ClinGen gnomAD |
|
|
rs1320398592 CA370980034 |
69 | L>I | No |
ClinGen gnomAD |
|
| TCGA novel | 71 | K>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA370979986 rs1293366513 |
75 | K>R | No |
ClinGen TOPMed gnomAD |
|
|
CA370979970 rs1425220041 |
77 | L>F | No |
ClinGen TOPMed |
|
|
CA370979150 rs1362275773 |
79 | G>R | No |
ClinGen TOPMed |
|
| TCGA novel | 81 | S>* | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA4750176 rs61748783 |
82 | T>A | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1159369417 CA370979111 |
82 | T>N | No |
ClinGen gnomAD |
|
|
rs61748783 CA177194144 |
82 | T>P | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA4750173 rs375610136 |
85 | D>E | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs61748782 CA370979056 |
86 | L>F | No |
ClinGen ExAC gnomAD |
|
|
rs61748782 CA4750172 |
86 | L>V | No |
ClinGen ExAC gnomAD |
|
|
rs1219946984 CA370979025 |
88 | E>G | No |
ClinGen gnomAD |
|
|
rs771234542 CA4750170 |
90 | K>Q | No |
ClinGen ExAC gnomAD |
|
| TCGA novel | 92 | E>* | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1288448709 CA370978951 |
93 | P>A | No |
ClinGen TOPMed gnomAD |
|
|
rs1054812114 CA177194116 |
94 | A>P | No |
ClinGen TOPMed |
|
|
CA177194110 rs764311439 |
94 | A>V | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
|
CA4750166 rs144176316 |
95 | I>V | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs770047485 CA4750165 |
97 | S>L | No |
ClinGen ExAC gnomAD |
|
|
rs903627179 CA177194066 |
99 | N>H | No |
ClinGen TOPMed |
|
|
CA177194059 rs1043890740 |
99 | N>S | No |
ClinGen TOPMed |
|
|
CA4750162 rs755021803 |
101 | P>R | No |
ClinGen ExAC gnomAD |
|
|
rs986979452 CA177194035 |
104 | R>* | No |
ClinGen TOPMed |
|
|
rs757079676 CA4750159 |
105 | E>G | No |
ClinGen ExAC gnomAD |
|
|
rs61740799 CA177194021 |
106 | E>K | No |
ClinGen Ensembl |
|
|
CA370978593 rs754476656 |
111 | G>C | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA4750135 rs754476656 |
111 | G>S | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
rs1338535367 CA370978588 |
112 | N>H | No |
ClinGen TOPMed gnomAD |
|
|
CA4750134 rs751076267 |
112 | N>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1337009716 CA370978579 |
113 | V>E | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed gnomAD |
|
CA370978573 rs1586006296 |
114 | S>N | No |
ClinGen Ensembl |
|
|
CA370978569 rs1381571651 |
114 | S>R | No |
ClinGen gnomAD |
|
|
CA370978566 rs1301271821 |
115 | N>H | No |
ClinGen gnomAD |
|
|
rs557599447 CA4750133 |
115 | N>K | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
CA370978557 rs1401400213 |
116 | R>I | No |
ClinGen gnomAD |
|
|
rs774735589 CA4750132 |
118 | D>G | No |
ClinGen ExAC TOPMed gnomAD |
|
| TCGA novel | 119 | E>* | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs773716419 CA4750131 |
120 | T>A | No |
ClinGen ExAC gnomAD |
|
|
rs371306322 CA4750130 |
121 | N>D | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs1202415874 CA370978503 |
122 | A>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen Ensembl NCI-TCGA |
|
rs776875502 CA4750128 |
123 | R>* | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
rs776875502 CA370978495 |
123 | R>G | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs747091310 CA4750127 |
123 | R>L | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs747091310 CA4750126 |
123 | R>Q | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
rs190781971 CA4750125 |
124 | D>N | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA370978450 rs374069934 |
126 | Y>* | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs1238499013 CA370978456 |
126 | Y>S | No |
ClinGen gnomAD |
|
|
CA177189408 rs933959208 |
131 | P>L | No |
ClinGen Ensembl |
|
|
rs1005850753 CA177189411 |
131 | P>S | No |
ClinGen TOPMed |
|
|
CA4750121 rs199869556 COSM273574 |
132 | R>W | Variant assessed as Somatic; 0.0 impact. pancreas large_intestine [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ExAC NCI-TCGA TOPMed gnomAD |
|
CA177189406 rs1037056970 |
133 | A>T | No |
ClinGen Ensembl |
|
|
CA4750120 rs769590882 |
134 | P>A | No |
ClinGen ExAC TOPMed gnomAD |
|
|
TCGA novel rs940240240 CA177189393 |
135 | S>R | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen gnomAD NCI-TCGA |
|
rs747930544 CA4750119 |
136 | T>I | No |
ClinGen ExAC gnomAD |
|
|
rs780873013 CA370978321 |
137 | S>A | No |
ClinGen ExAC gnomAD |
|
|
rs780873013 CA4750118 |
137 | S>T | No |
ClinGen ExAC gnomAD |
|
|
CA4750116 rs751060849 |
139 | S>F | No |
ClinGen ExAC gnomAD |
|
|
rs554296579 CA4750117 |
139 | S>P | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
CA4750114 rs757921440 |
140 | V>A | No |
ClinGen ExAC gnomAD |
|
|
CA370978256 rs1164293312 |
142 | L>F | No |
ClinGen gnomAD |
|
|
rs1442989856 CA370978235 |
144 | C>G | No |
ClinGen TOPMed |
|
|
CA370978221 rs1457997775 |
144 | C>W | No |
ClinGen gnomAD |
|
|
rs910169256 CA177189345 |
145 | R>K | No |
ClinGen Ensembl |
|
|
rs201165811 CA4750113 |
148 | L>I | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs765767710 CA4750112 |
149 | A>V | No |
ClinGen ExAC gnomAD |
|
|
CA4750111 rs754205500 |
150 | A>S | No |
ClinGen ExAC gnomAD |
|
|
CA4750110 rs754205500 |
150 | A>T | No |
ClinGen ExAC gnomAD |
|
|
CA370978142 rs1380752760 |
150 | A>V | No |
ClinGen gnomAD |
|
|
rs764364857 COSM263989 CA4750109 |
153 | R>Q | Variant assessed as Somatic; 0.0 impact. large_intestine endometrium [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ExAC NCI-TCGA TOPMed gnomAD |
|
rs200590980 CA4750105 |
155 | G>A | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs200590980 CA4750106 |
155 | G>E | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs200590980 CA4750108 |
155 | G>V | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs1172916870 CA370977965 |
156 | D>G | No |
ClinGen gnomAD |
|
|
rs1210291581 CA370978076 |
156 | D>H | No |
ClinGen TOPMed gnomAD |
|
| TCGA novel | 156 | D>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA370977961 rs1172916870 |
156 | D>V | No |
ClinGen gnomAD |
|
|
rs1210291581 CA370978074 |
156 | D>Y | No |
ClinGen TOPMed gnomAD |
|
|
CA177188507 rs1047179936 |
157 | D>N | No |
ClinGen TOPMed gnomAD |
|
|
rs1047179936 CA370977952 |
157 | D>Y | No |
ClinGen TOPMed gnomAD |
|
|
CA4750084 rs544980860 |
158 | Y>C | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
rs544980860 CA370977931 |
158 | Y>S | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
rs923177617 CA177188499 |
159 | I>L | No |
ClinGen TOPMed gnomAD |
|
|
CA4750083 rs774628452 |
161 | I>V | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs769761810 CA4750082 |
164 | D>V | No |
ClinGen ExAC gnomAD |
|
|
rs1465897199 CA370977842 |
165 | E>A | No |
ClinGen TOPMed |
|
| TCGA novel | 167 | E>K | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1025672723 CA177188443 |
170 | S>C | No |
ClinGen TOPMed |
|
|
rs1025672723 CA177188459 |
170 | S>F | No |
ClinGen TOPMed |
|
|
rs1269322059 CA370977701 |
175 | A>T | No |
ClinGen gnomAD |
|
|
CA370977315 rs1471932982 |
175 | A>V | No |
ClinGen gnomAD |
|
|
rs536110770 CA4750056 |
176 | I>V | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
CA370977281 rs1179630541 |
178 | Q>R | No |
ClinGen gnomAD |
|
|
CA4750055 rs776395821 |
182 | N>H | No |
ClinGen ExAC gnomAD |
|
|
CA370977220 rs1181195458 |
183 | T>A | No |
ClinGen TOPMed |
|
|
CA370977215 rs1236920540 |
183 | T>R | No |
ClinGen gnomAD |
|
|
rs1244664983 CA370977198 |
184 | D>E | No |
ClinGen TOPMed |
|
|
CA177186120 rs939960872 |
185 | M>I | No |
ClinGen TOPMed |
|
|
rs1204359915 CA370977156 |
187 | Y>C | No |
ClinGen gnomAD |
|
|
rs764136240 CA4750054 |
191 | V>I | No |
ClinGen ExAC gnomAD |
|
|
rs760444974 CA370977096 |
192 | R>* | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
rs760444974 CA4750053 |
192 | R>G | No |
ClinGen ExAC gnomAD |
|
|
CA4750052 rs775322544 |
192 | R>Q | No |
ClinGen ExAC gnomAD |
|
|
rs771708577 CA4750051 |
193 | S>N | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA4750049 rs774068260 |
195 | I>M | No |
ClinGen ExAC |
|
|
CA4750050 rs745459376 |
195 | I>V | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA177186093 rs908195188 |
199 | K>* | No |
ClinGen TOPMed |
|
|
rs1378782348 CA370976995 |
200 | D>V | No |
ClinGen gnomAD |
|
|
CA16040541 rs1306991920 |
201 | A>T | No |
ClinGen TOPMed gnomAD |
|
| TCGA novel | 203 | N>I | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs770305078 CA4750048 |
205 | N>D | No |
ClinGen ExAC TOPMed gnomAD |
|
| TCGA novel | 206 | L>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs748867181 CA4750047 |
209 | N>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA4750046 rs778119736 |
211 | L>P | No |
ClinGen ExAC gnomAD |
|
|
rs1365212746 CA370976862 COSM3395357 |
211 | L>V | pancreas [Cosmic] | No |
ClinGen cosmic curated gnomAD |
|
rs1446342162 CA370976842 |
212 | C>W | No |
ClinGen TOPMed |
|
|
CA177186044 rs981113380 |
213 | G>R | No |
ClinGen TOPMed gnomAD |
|
|
CA370976819 rs1319145051 |
214 | N>T | No |
ClinGen TOPMed |
|
|
rs755404716 CA4750041 |
216 | P>L | No |
ClinGen ExAC gnomAD |
|
|
CA4750042 rs755404716 |
216 | P>R | No |
ClinGen ExAC gnomAD |
|
|
rs748514928 CA4750043 |
216 | P>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs575259192 CA177185996 |
218 | D>E | No |
ClinGen TOPMed gnomAD |
|
|
rs751685890 CA4750040 |
225 | A>T | No |
ClinGen ExAC gnomAD |
|
| rs963722279 | 226 | E>= | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1192788856 CA370976357 |
227 | E>K | No |
ClinGen TOPMed |
|
|
rs772596271 CA177181794 |
236 | M>T | No |
ClinGen Ensembl |
|
|
CA4750020 rs200499230 |
237 | R>Q | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
CA370976280 COSM1457514 rs1288459076 |
237 | R>W | Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated NCI-TCGA TOPMed gnomAD |
|
rs758708704 CA4750018 |
238 | K>N | No |
ClinGen ExAC gnomAD |
|
|
rs1174589663 CA370976269 |
239 | N>D | No |
ClinGen gnomAD |
|
|
CA4750017 rs750465931 |
239 | N>T | No |
ClinGen ExAC gnomAD |
|
|
CA370976246 rs1460555619 |
242 | K>R | No |
ClinGen gnomAD |
|
|
rs762271675 CA177181770 |
248 | H>Y | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen Ensembl NCI-TCGA |
|
CA177181762 rs965028555 |
252 | K>R | No |
ClinGen TOPMed gnomAD |
|
|
rs368515547 CA4750014 |
254 | G>S | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA4750013 rs767481992 |
261 | F>L | No |
ClinGen ExAC TOPMed gnomAD |
|
| TCGA novel | 263 | C>Y | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
| TCGA novel | 266 | C>E | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs759228331 CA4750012 |
269 | K>R | No |
ClinGen ExAC gnomAD |
|
|
CA4750011 rs751428994 |
270 | N>S | No |
ClinGen ExAC gnomAD |
|
|
CA370976031 rs1370259928 |
272 | T>I | No |
ClinGen TOPMed |
|
|
CA370976029 rs1220582275 |
273 | Y>H | No |
ClinGen TOPMed |
|
|
CA370986896 rs1313130606 |
276 | V>L | No |
ClinGen gnomAD |
|
|
CA370986818 rs1378027814 |
281 | A>T | Variant assessed as Somatic; 4.668e-05 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
|
CA4749997 rs201107451 |
285 | M>V | No |
ClinGen 1000Genomes ExAC gnomAD |
|
| TCGA novel | 287 | T>A | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA370986703 rs1390156019 |
289 | V>F | No |
ClinGen gnomAD |
|
|
CA4749994 rs558253108 |
293 | E>Q | No |
ClinGen ExAC TOPMed gnomAD |
1 associated diseases with P23193
Without disease ID
4 regional properties for P23193
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Zinc finger, TFIIS-type | 259 - 300 | IPR001222 |
| domain | Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type | 5 - 79 | IPR003617 |
| domain | Transcription elongation factor S-II, central domain | 136 - 256 | IPR003618 |
| domain | Transcription factor IIS, N-terminal | 3 - 80 | IPR017923 |
4 GO annotations of cellular component
| Name | Definition |
|---|---|
| nucleolus | A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome. |
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| transcription factor TFIID complex | A complex composed of TATA binding protein (TBP) and TBP associated factors (TAFs); the total mass is typically about 800 kDa. Most of the TAFs are conserved across species. In TATA-containing promoters for RNA polymerase II (Pol II), TFIID is believed to recognize at least two distinct elements, the TATA element and a downstream promoter element. TFIID is also involved in recognition of TATA-less Pol II promoters. Binding of TFIID to DNA is necessary but not sufficient for transcription initiation from most RNA polymerase II promoters. |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| DNA binding | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
| zinc ion binding | Binding to a zinc ion (Zn). |
4 GO annotations of biological process
| Name | Definition |
|---|---|
| DNA-templated transcription | The synthesis of an RNA transcript from a DNA template. |
| positive regulation of transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| transcription by RNA polymerase II | The synthesis of RNA from a DNA template by RNA polymerase II (RNAP II), originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs). |
| transcription elongation by RNA polymerase II promoter | The extension of an RNA molecule after transcription initiation and promoter clearance at an RNA polymerase II promoter by the addition of ribonucleotides catalyzed by RNA polymerase II. |
7 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| A5PKE4 | TCEANC2 | Transcription elongation factor A N-terminal and central domain-containing protein 2 | Bos taurus (Bovine) | PR |
| Q96MN5 | TCEANC2 | Transcription elongation factor A N-terminal and central domain-containing protein 2 | Homo sapiens (Human) | PR |
| Q8R2M0 | Tceanc2 | Transcription elongation factor A N-terminal and central domain-containing protein 2 | Mus musculus (Mouse) | PR |
| P23881 | Tcea3 | Transcription elongation factor A protein 3 | Mus musculus (Mouse) | PR |
| P10711 | Tcea1 | Transcription elongation factor A protein 1 | Mus musculus (Mouse) | PR |
| Q5XIC7 | Tceanc2 | Transcription elongation factor A N-terminal and central domain-containing protein 2 | Rattus norvegicus (Rat) | PR |
| P52652 | T24H10.1 | Putative transcription elongation factor S-II | Caenorhabditis elegans | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MEDEVVRFAK | KMDKMVQKKN | AAGALDLLKE | LKNIPMTLEL | LQSTRIGMSV | NAIRKQSTDE |
| 70 | 80 | 90 | 100 | 110 | 120 |
| EVTSLAKSLI | KSWKKLLDGP | STEKDLDEKK | KEPAITSQNS | PEAREESTSS | GNVSNRKDET |
| 130 | 140 | 150 | 160 | 170 | 180 |
| NARDTYVSSF | PRAPSTSDSV | RLKCREMLAA | ALRTGDDYIA | IGADEEELGS | QIEEAIYQEI |
| 190 | 200 | 210 | 220 | 230 | 240 |
| RNTDMKYKNR | VRSRISNLKD | AKNPNLRKNV | LCGNIPPDLF | ARMTAEEMAS | DELKEMRKNL |
| 250 | 260 | 270 | 280 | 290 | 300 |
| TKEAIREHQM | AKTGGTQTDL | FTCGKCKKKN | CTYTQVQTRS | ADEPMTTFVV | CNECGNRWKF |
| C |